Findings add to growing evidence implicating ApoER2-Dab1 pathway disruption in AD-related neurodegeneration, and suggest that compromised function of the ApoER2-Dab1 pathway in amygdala could contribute to cognitive and neuropsychiatric manifestations of AD. The gene discussed is DAB1; the disease is Alzheimer disease.